Collaboration with industry is the key to real-life solutions
Business development is a key element of VIB’s overarching vision, and involves a blend of good science, business and communication to be successful. Collaborating with industry is one way of advancing research and bringing innovation and technological development to consumers, patients and farmers. Our Business Development team enables the essential links between VIB scientists and industry, taking VIB’s research results to the next level. Since the start, VIB has forged long-term strategic alliances focused on specific areas of research.
VIB’s Business Development team
VIB’s Business Development team combines the strengths of academia and industry. We strike deals with companies based on a strong patent portfolio and knowledge basis, an active marketing of the know-how, and a flexible, tailor-made approach to negotiating partnerships.
Jan Staelens, Head of Business Development at VIB:
“Business Development is not all about commercialization – two-way learning is also an important result. We often gain valuable insights into how to move projects forward from partner companies and organizations”.
VIB pro-actively markets its proprietary knowledge and portfolio of hundreds of patents and patent applications to businesses around the world that are willing to diligently develop products derived from VIB research. VIB inked more than 1500 agreements with local and international companies, with small enterprises and multinationals, and in areas as diverse as the food, biopharmaceutical, and agricultural industry.
We encourage you to contact our team to explore opportunities for licensing, research cooperation, and partnerships.
Research services for life sciences companies
VIB offers access to specialized equipment and services housed at ten Core Facilities, which are fully adapted to the needs of the wider scientific community. The Cores provide state-of-the-art servicing in transcriptomics, genomics, proteomics, protein and antibody engineering, advanced light and electron microscopy, assay design, and proof-of-concept screens.
On their way to patients, consumers and farmers
There are several candidate drugs derived from VIB research undergoing clinical testing. These new therapeutic agents offer hope to people suffering from diseases such as cancer, arthritis or infectious and cardiovascular illnesses. Concerning our green pipeline, in partnership with AgBio companies, agricultural innovations based on VIB research are currently being tested.